Stem Cell Therapeutic and Research Reauthorization Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 26, 2019)
Stem Cell Therapeutic and Research Reauthorization Act of 2019
This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.
The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.
What just happenedJun 27, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 26, 2019
- Jun 27, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 26, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jun 26, 2019IntroReferralIntro-H
Introduced in House
- Jun 26, 2019IntroReferral1000
Introduced in House